Cabergoline in the Treatment of Peripartum Cardiomyopathy - Revista Brasileira de Ginecologia e Obstetrícia

Home » Issues » 2016, Volume 38, Number 8

Letter to the Editor

Cabergoline in the Treatment of Peripartum Cardiomyopathy

Rev Bras Ginecol Obstet. 2016;38(8):423-424

DOI: 10.1055/s-0036-1592295

Views 3

It is premature to make a recommendation for treatment of peripartum cardiomyopathy (PPCM) with prolactin inhibition (bromocriptine or cabergoline) as in the one-case report of Melo et al.

There are now multiple reports of trials for PPCM subjects in the use prolactin inhibition treatment compared with non-use of this modality that show no statistically significant benefit in recovery outcomes at 6 and 12 months postpartum.,

[…]

Read Full Text

opener
PDF - English Complete text JATS XML
How to Cite
Mendeley

Search

Search in:

Article type
abstract
book-review
brief-report
case-report -
correction
editorial
editorial -
letter
letter -
other -
rapid-communication
research-article
research-article -
review-article
review-article -
Section
Abstracts of Awarded Papers at the 50th Brazilian Congress of Gynecology and Obstetrics
Artigo de Revisão
Original Articles
Carta ao Editor
Case Report
Case Report and Treatment
Clinical Consensus Recommendation
Editorial
Editorial
Equipments and Methods
Erratum
Febrasgo Position Statement
Letter to the Editor
Methods and Techniques
Nota do Editor
Original Article
Original Article/Contraception
Original Article/Infertility
Original Article/Obstetrics
Original Article/Oncology
Original Article/Sexual Violence/Pediatric and Adolescent Gynecology
Original Article/Teaching and Training
Original Articles
Original Articles
Previous Note
Relato de Caso
Relatos de Casos
Resposta dos Autores
Resumo De Tese
Resumos de Teses
Review Article
Short Communication
Special Article
Systematic Review
Técnicas e Equipamentos
Thesis Abstract
Trabalhos Originais
Year / Volume
2024; v.46
2023; v.45
2022; v.44
2021; v.43
2020; v.42
2019; v.41
2018; v.40
2017; v.39
2016; v.38
2015; v.37
2014; v.36
2013; v.35
2012; v.34
2011; v.33
2010; v.32
2009; v.31
2008; v.30
2007; v.29
2006; v.28
2005; v.27
2004; v.26
2003; v.25
2002; v.24
2001; v.23
2000; v.22
1999; v.21
1998; v.20
ISSUE

Comments

Your email address will not be published. Required fields are marked *

Read Full Text

opener
PDF - English Complete text JATS XML
How to Cite
Mendeley

Search

Search in:

Article type
abstract
book-review
brief-report
case-report -
correction
editorial
editorial -
letter
letter -
other -
rapid-communication
research-article
research-article -
review-article
review-article -
Section
Abstracts of Awarded Papers at the 50th Brazilian Congress of Gynecology and Obstetrics
Artigo de Revisão
Original Articles
Carta ao Editor
Case Report
Case Report and Treatment
Clinical Consensus Recommendation
Editorial
Editorial
Equipments and Methods
Erratum
Febrasgo Position Statement
Letter to the Editor
Methods and Techniques
Nota do Editor
Original Article
Original Article/Contraception
Original Article/Infertility
Original Article/Obstetrics
Original Article/Oncology
Original Article/Sexual Violence/Pediatric and Adolescent Gynecology
Original Article/Teaching and Training
Original Articles
Original Articles
Previous Note
Relato de Caso
Relatos de Casos
Resposta dos Autores
Resumo De Tese
Resumos de Teses
Review Article
Short Communication
Special Article
Systematic Review
Técnicas e Equipamentos
Thesis Abstract
Trabalhos Originais
Year / Volume
2024; v.46
2023; v.45
2022; v.44
2021; v.43
2020; v.42
2019; v.41
2018; v.40
2017; v.39
2016; v.38
2015; v.37
2014; v.36
2013; v.35
2012; v.34
2011; v.33
2010; v.32
2009; v.31
2008; v.30
2007; v.29
2006; v.28
2005; v.27
2004; v.26
2003; v.25
2002; v.24
2001; v.23
2000; v.22
1999; v.21
1998; v.20
ISSUE

Leia também

close-button

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Fett JD. Cabergoline in the Treatment of Peripartum Cardiomyopathy. Rev Bras Ginecol Obstet 2016;38(8):423-4.

Electronic Document Format (ABNT)

Fett, James D.. Cabergoline in the Treatment of Peripartum Cardiomyopathy. Rev Bras Ginecol Obstet, v. 38, n. 8, p. 423-424, Aug. 2016.

Electronic Document Format (APA)

Fett, J. D. (2016). Cabergoline in the Treatment of Peripartum Cardiomyopathy. Rev Bras Ginecol Obstet, 38(8), 423-424.

Electronic Document Format (ISO)

Fett, James D.. Cabergoline in the Treatment of Peripartum Cardiomyopathy. Rev Bras Ginecol Obstet [online]. 2016, vol. 38, n. 8, [cited 2024-07-02], pp.423-424. Available from: <https://journalrbgo.org/article/cabergoline-in-the-treatment-of-peripartum-cardiomyopathy/>.
✕

Cabergoline in the Treatment of Peripartum Cardiomyopathy |

It is premature to make a recommendation for treatment of peripartum cardiomyopathy (PPCM) with prolactin inhibition (bromocriptine or cabergoline) as in the one-case report of Melo et al.

There are now multiple reports of trials for PPCM subjects in the use prolactin inhibition treatment compared with non-use of this modality that show no statistically significant benefit in recovery outcomes at 6 and 12 months postpartum.,

[...]